全文获取类型
收费全文 | 14667篇 |
免费 | 1049篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 90篇 |
儿科学 | 296篇 |
妇产科学 | 237篇 |
基础医学 | 2106篇 |
口腔科学 | 137篇 |
临床医学 | 1934篇 |
内科学 | 3563篇 |
皮肤病学 | 324篇 |
神经病学 | 1236篇 |
特种医学 | 600篇 |
外国民族医学 | 4篇 |
外科学 | 2259篇 |
综合类 | 49篇 |
一般理论 | 6篇 |
预防医学 | 670篇 |
眼科学 | 279篇 |
药学 | 994篇 |
中国医学 | 25篇 |
肿瘤学 | 976篇 |
出版年
2023年 | 89篇 |
2022年 | 146篇 |
2021年 | 420篇 |
2020年 | 222篇 |
2019年 | 348篇 |
2018年 | 419篇 |
2017年 | 293篇 |
2016年 | 312篇 |
2015年 | 395篇 |
2014年 | 538篇 |
2013年 | 708篇 |
2012年 | 1095篇 |
2011年 | 1202篇 |
2010年 | 622篇 |
2009年 | 595篇 |
2008年 | 886篇 |
2007年 | 905篇 |
2006年 | 892篇 |
2005年 | 841篇 |
2004年 | 778篇 |
2003年 | 742篇 |
2002年 | 695篇 |
2001年 | 237篇 |
2000年 | 227篇 |
1999年 | 209篇 |
1998年 | 149篇 |
1997年 | 124篇 |
1996年 | 102篇 |
1995年 | 70篇 |
1994年 | 64篇 |
1993年 | 68篇 |
1992年 | 122篇 |
1991年 | 113篇 |
1990年 | 96篇 |
1989年 | 97篇 |
1988年 | 97篇 |
1987年 | 89篇 |
1986年 | 91篇 |
1985年 | 69篇 |
1984年 | 48篇 |
1983年 | 49篇 |
1982年 | 37篇 |
1981年 | 36篇 |
1980年 | 37篇 |
1979年 | 44篇 |
1978年 | 35篇 |
1975年 | 35篇 |
1974年 | 24篇 |
1973年 | 27篇 |
1972年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
131.
Sybille Rousseau Matthieu Peycelon Céline Grosos Valeska Bidault Anna Poupalou Garance Martin Éric Dobremez Luke Harper Claire Raquillet Alexis Arnaud Emmanuel Sapin Aurélien Scalabre Philippe Buisson Guillaume Levard Isabelle Pommepuy Maguelonne Pons Laurent Fourcade Quentin Ballouhey 《Journal of pediatric surgery》2021,56(2):332-336
IntroductionFibroepithelial polyps (FEP) of the lower urinary tract are relatively common in adults but rare in children, with fewer than 250 cases reported in the literature to date.ObjectiveThe aim of this study was to address the experience of FEP management in children.Study designA retrospective multicenter review was undertaken in children with defined FEP of the lower urinary tract managed between 2008 and 2018. The data at 18 pediatric surgery centers were collected. Their demographic, radiological, surgical, and pathological information were reviewed.ResultsA total of 33 children (26 boys; 7 girls) were treated for FEP of the lower urinary tract at 13 centers. The most common presentation was urinary outflow as hematuria (41%), acute urinary retention (25%), dysuria (19%), or urinary infections (28%). A prenatal diagnosis was made for three patients with hydronephrosis. Almost all of the children (94%) underwent ultrasound imaging of the urinary tract as the first diagnostic examination, 23 (70%) of them also either had an MRI (15%), cystourethrography (25%), computerized tomography (6%), or cystoscopy (45%). Two of these children (6%) had a biopsy prior to the surgery. The median preoperative delay was 7.52 (range: 1–48) months. Most of the patients were treated endoscopically, although four (12.1%) had open surgery and two (6.1%) had an additional incision for specimen extraction. The median hospital stay was 1.5 (range: 1–10) days. There were no recurrences and no complications after a median follow-up of 13 (range: 1–34) months.DiscussionThe main limitation of our study is the retrospective design, although it is the largest one for this pathology.ConclusionThis series supports sonography as the most suitable diagnosis tool before endoscopy to confirm the diagnosis and to perform the resection for most FEP in children. This report confirms the recognized benign nature in the absence of recurrences.Level of EvidenceLevel V. 相似文献
132.
133.
134.
135.
136.
137.
Benjamin Coiffard Philipp M. Lepper Eloi Prud’Homme Florence Daviet Nadim Cassir Heinrike Wilkens Sami Hraiech Frank Langer Pascal A. Thomas Martine Reynaud-Gaubert Robert Bals Hans-Joachim Schäfers Laurent Papazian Frederik Seiler 《American journal of transplantation》2021,21(4):1586-1596
It is unknown if solid organ transplant recipients are at higher risk for severe COVID-19. The management of a lung transplantation (LTx) program and the therapeutic strategies to adapt the immunosuppressive regimen and antiviral measures is a major issue in the COVID-19 era, but little is known about worldwide practice. We sent out to 180 LTx centers worldwide in June 2020 a survey with 63 questions, both regarding the management of a LTx program in the COVID-19 era and the therapeutic strategies to treat COVID-19 LTx recipients. We received a total of 78 responses from 15 countries. Among participants, 81% declared a reduction of the activity and 47% restricted LTx for urgent cases only. Sixteen centers observed deaths on waiting listed patients and eight centers performed LTx for COVID-19 disease. In 62% of the centers, COVID-19 was diagnosed in LTx recipients, most of them not severe cases. The most common immunosuppressive management included a decreased dose or pausing of the cell cycle inhibitors. Remdesivir, hydroxychloroquine, and azithromycin were the most proposed antiviral strategies. Most of the centers have been affected by the COVID-19 pandemic and proposed an active therapeutic strategy to treat LTx recipients with COVID-19. 相似文献
138.
Christof Ernst Berberich J r me Josse Fr d ric Laurent Tristan Ferry 《World journal of orthopedics》2021,12(3):119-128
In view of the demographic changes and projected increase of arthroplasty procedures worldwide, the number of prosthetic joint infection cases will naturally grow. Therefore, in order to counteract this trend more rigid rules and a stricter implementation of effective preventive strategies is of highest importance. In the absence of a "miracle weapon" priorities should lie in evidence-based measures including preoperative optimization of patients at higher infection risks, the fulfilment of strict hygiene rules in the operating theatre and an effective antibiotic prophylaxis regimen. Instead of a "one size fits all" philosophy, it has been proposed to adjust the antibiotic prophylaxis protocol to major infection risks taking into account important patient-and procedure-related risk factors. A stronger focus on the local application mode via use of high dose dual antibioticloaded bone cement in such risk situations may have its advantages and is easy to apply in the theatre. The more potent antimicrobial growth inhibition in vitro and the strong reduction of the prosthetic joint infection rate in risk for infection patients with aid of dual antibiotic-loaded bone cement in clinical studies align with this hypothesis. 相似文献
139.